TENCENT (00700) will hold a board meeting today to approve its full-year 2025 financial results, scheduled for release on March 18, 2026. Based on institutional forecasts and market analysis, the company's AI progress is expected to be reflected in the report beyond mere strategic statements, with concrete details across four key areas: financial data, business penetration rates, capital expenditure structure, and ecosystem restructuring. The market's primary focus is whether AI has transitioned from a cost center to a revenue generator. Preliminary reports indicate the full-year 2025 gross profit margin is projected to improve to approximately 56% year-over-year. The financial results will highlight the proportion of advertising revenue driven by AI, detailing how AI technology assists small and medium-sized businesses in automatically generating advertising materials, thereby contributing to incremental income from long-tail customers.
In broader market trends, the three major U.S. stock indices recorded slight gains, with most large-cap technology stocks advancing. At the close, the Dow Jones Industrial Average rose 46.85 points to 46,993.26, a 0.1% increase. The S&P 500 index added 16.71 points to 6,716.09, up 0.25%, while the Nasdaq Composite Index climbed 105.35 points to 22,479.53, a gain of 0.47%. Several memory chip stocks reached record closing highs, with Western Digital surging over 9% and Micron Technology rising more than 4%. Meanwhile, most popular U.S.-listed Chinese stocks declined, pulling the Nasdaq Golden Dragon China Index down 0.73%. Hong Kong's Hang Seng Index ADRs edged higher, implying an opening up 36.39 points or 0.14% at 25,904.93. In commodities, the front-month WTI crude oil futures contract on the NYMEX rose $2.52 to settle at $96.02 per barrel, a 2.70% gain. COMEX gold futures for the front month increased by $9.10, or 0.18%, to $5,011.3 per ounce.
Key corporate updates include Fosun International (00656) announcing that its subsidiary Fidelidade reported an annual net profit of €258 million for the year ended December 31, 2025, with insurance contract revenue of €4.033 billion. China East Education (00667) released its 2025 annual results, showing revenue of RMB 4.616 billion, a 12.1% increase, and a net profit of RMB 756 million, up 47.5% year-over-year. An adjusted net profit of RMB 792 million represented growth of 50.9%. A final dividend of HK$0.30 per share was proposed. Wasion Holdings (03393) announced its Brazilian subsidiary successfully secured a supply contract from Companhia Energética de Minas Gerais S.A. (CEMIG), one of Brazil's largest power companies, to be the sole supplier of reclosers. The contract, valued at approximately BRL 138 million, is to be delivered over the next two years. HK Electric-SS (02638) reported a 1.2% rise in annual profit attributable to holders to HK$3.149 billion for 2025.
Several companies issued positive profit alerts. Huadian Hotel (00201) expects a 49% increase in its owner’s net profit, excluding revaluation and non-cash depreciation, to HK$155 million for the 2025 fiscal year, attributed to higher hotel revenue and reduced operating and finance costs. Kingdee International (00268) returned to profitability in 2025, with net profit attributable to shareholders of approximately RMB 92.914 million, highlighting successful subscription model transformation and accelerated AI and global expansion. China Literature (00772) reported annual revenue of approximately RMB 7.366 billion, with GMV from derivative products surpassing RMB 1.1 billion. ZTO Express-W (02057) announced a 3.9% increase in full-year net profit to RMB 9.236 billion. Lemongrass Films (09857) projected a turnaround to a net profit between RMB 20 million and RMB 40 million for 2025.
Other notable results included Fuyao Glass (03606) posting a 24.2% rise in net profit to approximately RMB 9.312 billion, while SMOORE International (06969) saw an 18.5% decline in annual profit to about RMB 1.062 billion. Innovation Industries (02788) plans acquisitions totaling over RMB 1.5 billion and reported a 32.81% increase in annual net profit. Xipuri (02583) announced a 106.5% surge in net profit to RMB 102 million. Tencent Music-SW (01698) reported a 66.4% jump in annual profit attributable to shareholders to RMB 11.06 billion.
In a key development for the pharmaceutical sector, Ascletis Pharma-B (01672) announced the selection of ASC39, an oral small molecule amylin receptor agonist, as a clinical candidate. Preclinical models demonstrated amylin selectivity and efficacy comparable to eloralintide. The company plans to submit an IND to the U.S. FDA in the third quarter of 2026 for ASC39 as a treatment for obesity, both as a monotherapy and in combination with its GLP-1 candidate, ASC30. The candidate was discovered using the company's proprietary AI-assisted structure-based drug discovery technology.
Comments